U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for AdultsPRNewsWire • 10/19/22
Novavax (NVAX) Reports Positive Data on COVID/FLU Combo Jab StudyZacks Investment Research • 10/14/22
Novavax says its combination COVID-19 and flu vaccine produced an immune responseMarket Watch • 10/13/22
Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody and T-Cell Responses Against SARS-CoV-2 and Homologous and Heterologous Influenza StrainsPRNewsWire • 10/13/22
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against VariantsPRNewsWire • 10/12/22
Novavax to Share New Data from Growing Vaccine Portfolio at World Vaccine Congress Europe 2022PRNewsWire • 10/10/22
Novavax Is No Longer Expected To Become Profitable This Year — Is It A Sell?Investors Business Daily • 10/04/22